| Literature DB >> 27467859 |
Claire M Grison1, Jennifer A Miles2,3, Sylvie Robin1,4, Andrew J Wilson5,6, David J Aitken7.
Abstract
A major current challenge in bioorganic chemistry is the identification of effective mimics of protein secondary structures that act as inhibitors of protein-protein interactions (PPIs). In this work, trans-2-aminocyclobutanecarboxylic acid (tACBC) was used as the key β-amino acid component in the design of α/β/γ-peptides to structurally mimic a native α-helix. Suitably functionalized α/β/γ-peptides assume an α-helix-mimicking 12,13-helix conformation in solution, exhibit enhanced proteolytic stability in comparison to the wild-type α-peptide parent sequence from which they are derived, and act as selective inhibitors of the p53/hDM2 interaction.Entities:
Keywords: foldamers; inhibitors; peptidomimetics; protein-protein interactions; α-helix mimetics
Mesh:
Substances:
Year: 2016 PMID: 27467859 PMCID: PMC5014220 DOI: 10.1002/anie.201604517
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336
Figure 1Alignment of key side chains. a) The p53(19—26) segment. b) Structures of the α/β/γ‐peptide helix mimetics (1–8) studied in this work.
Figure 2Conformational analyses of peptides 1–8. a) Structures of N‐Boc‐protected α/β/γ‐peptides 1–4, highlighting significant 1H NMR data (10 mm in CDCl3): amide NH signals with high [D6]DMSO titration coefficients (in green) and ROEs observed between non‐adjacent residues (blue arrows). b) The same structures of 1–4 showing the interpretation of the above data in terms of a 12,13‐helix, comprised of a succession of 12‐ and 13‐membered hydrogen‐bonded rings (pink and red, respectively). c) IR absorption spectra (10 mm in CDCl3) of N‐Boc‐protected α/β/γ‐peptides 1–4. d) CD spectra (0.2 mm in MeOH) of α/β/γ‐peptides 1–8.
Figure 3Molecular modelling of α/β/γ‐peptides. a) Superimposition of the calculated lowest‐energy conformers of α/β/γ‐peptides 1—4. b) The same such structures of peptides 5—8. C yellow, N blue and O red. c) Representation of the crystal structure of p5316–29 excised from its complex with hDM2 (PDB ID: 1YCR) highlighting the helical backbone (in red) and the hot‐spot side chains (in green). d) Overlays of the backbones of α/β/γ‐peptide 2 (yellow backbone) and of p5316–29 peptide (red backbone); RMSD is 0.89 Å for the α‐carbons. e) Hot‐spot matching. Colors as for (c) and (d).
Figure 4Biophysical analysis of the α/β/γ‐peptides. a) proteolytic degradation of peptides 1–8 and p5315–31. b, c) Dose–response curves for 1–4 (b) and 5–8 (c) in an FA competition assay against p53/hDM2 (50 nm of FITC–p53 and 150 nm of hDM2 in 40 mm phosphate buffer, pH 7.5, 200 mm NaCl, 0.02 mg mL−1 BSA, 5 % DMSO). d) 1H‐15N HSQC spectra of 15N‐labelled hDM2 (87 μm in 100 mm sodium phosphate buffer, pH 7.3, 2.5 % glycerol, 1 mm DTT, 5 % DMSO), recorded in the absence (black) and the presence (red) of 200 μm 2 (left), with cross‐peaks that move mapped onto the surface of hDM2 and shown in blue (right). BSA=bovine serum albumin, DMSO=dimethyl sulfoxide, DTT=1,4‐dithiothreitol.